The first generic versions of the antidepressant drug Cymbalta (duloxetine delayed-release capsules) have been approved by the U.S. Food and Drug Administration. License to produce generic Cymbalta was granted to Aurobindo Pharma Ltd., ...
Tags: antidepressant drug, Cymbalta, duloxetine delayed-release capsules
The U.S. Food and Drug Administration approved the first generic versions of Cymbalta, a drug used to treat depression and other conditions, officials say. Dr. Kathleen Uhl, acting director of the Office of Generic Drugs in the FDA's ...
Eli Lilly and Company has reported a net income of $827.2m, or $0.74 per diluted share, for the fourth quarter ended 31 December 2012 compared to $858.2m, or $0.77 per diluted share, for the fourth quarter ended 31 December 2011. Total ...
Tags: Eli Lilly, net income, share
Eli Lilly and Company has met the United States Food and Drug Administration (FDA) requirements for pediatric exclusivity for Cymbalta (duloxetine HCl), which is available in 20-mg, 30-mg, and 60-mg capsules. As part of the approval, ...